Here, Kobayashi et al. showed that IL-6 blockade during the injury phase prevented the apoptosis of type II pneumocytes and markedly accelerated fibrosis, while IL-6 blockade at the early fibrotic phase ameliorated lung fibrosis. This evidence concerns the gene IL6 and pulmonary fibrosis.